| Year |
Title |
Altmetric |
| 2022
|
Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma..
Laboratory Investigation.
102:1236-1244.
2022
|
|
| 2022
|
Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma.
Laboratory Investigation.
102:1236-1244.
2022
|
|
| 2022
|
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.
Cancer Research.
82:2344-2353.
2022
|
|
| 2022
|
Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.
Molecular Cancer Research.
20:150-160.
2022
|
|
| 2021
|
Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages.
Cancer Research.
81:5425-5437.
2021
|
|
| 2021
|
Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis.
Laboratory Investigation.
101:1439-1448.
2021
|
|
| 2021
|
Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis..
Laboratory Investigation.
101:1439-1448.
2021
|
|
| 2021
|
Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding.
Cancer Letters.
517:24-34.
2021
|
|
| 2021
|
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors.
Oncogenesis.
10.
2021
|
|
| 2021
|
Merlin deficiency alters the redox management program in breast cancer.
Molecular Oncology.
15:942-956.
2021
|
|
| 2021
|
Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.
Cell Death and Disease.
12.
2021
|
|
| 2021
|
Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA.
iScience.
24.
2021
|
|
| 2021
|
Isolation of Nucleoli for Characterization of Nucleolar Contents to Uncover Clues to Metastatic Progression.
Methods in Molecular Biology.
2294:269-274.
2021
|
|
| 2020
|
Hedgehog signaling enables repair of ribosomal DNA double-strand breaks.
Nucleic Acids Research.
48:10342-10352.
2020
|
|
| 2019
|
The nucleolus: a central response hub for the stressors that drive cancer progression.
Cellular and Molecular Life Sciences.
76:4511-4524.
2019
|
|
| 2019
|
Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer.
OncoImmunology.
8.
2019
|
|
| 2019
|
O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity.
Laboratory Investigation.
99:260-270.
2019
|
|
| 2018
|
Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer.
Carcinogenesis.
39:1165-1175.
2018
|
|
| 2018
|
Abstract 4043: A novel role for Hedgehog signaling in macrophage-mediated immune evasion.
Cancer Research.
78:4043-4043.
2018
|
|
| 2018
|
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer [Oncotarget., 7, (2016) (86803-86815)] 10.18632/oncotarget.13466.
Oncotarget.
9:19459-19459.
2018
|
|
| 2018
|
Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors.
Oncogene.
37:1610-1623.
2018
|
|
| 2018
|
Evaluating the use of external beam radiation alone in the management of cervix cancer.
Journal of Radiotherapy in Practice.
17:37-43.
2018
|
|
| 2018
|
Phage ligands for identification of mesenchymal-like breast cancer cells and cancer-associated fibroblasts.
Frontiers in Oncology.
8.
2018
|
|
| 2017
|
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model.
Scientific Reports.
7.
2017
|
|
| 2017
|
Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
PLoS One.
12.
2017
|
|
| 2017
|
Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.
Clinical and Experimental Metastasis.
34:443-447.
2017
|
|
| 2017
|
TMIC-07. HIGH ALDEHYDE DEHYDROGENASE ACTIVITY IDENTIFIES BRAIN METASTASIS-INITIATING CELLS IN BREAST CANCER.
Neuro-Oncology.
19:vi244-vi244.
2017
|
|
| 2017
|
TMIC-31. MLK4 IS REQUIRED FOR METASTASIS INITIATION IN THE BRAIN.
Neuro-Oncology.
19:vi250-vi250.
2017
|
|
| 2017
|
Developing Cures: Targeting Ontogenesis in Cancer.
Trends in Cancer.
3:126-136.
2017
|
|
| 2017
|
Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling.
Scientific Reports.
7.
2017
|
|
| 2016
|
Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
Oncotarget.
7:53984-53996.
2016
|
|
| 2016
|
Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.
International Journal of Cancer.
139:491-500.
2016
|
|
| 2016
|
Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.
Oncotarget.
7:17991-18005.
2016
|
|
| 2016
|
Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer.
Oncotarget.
7:86803-86815.
2016
|
|
| 2015
|
Nuclear Localization of DNAJB6 Is Associated with Survival of Patients with Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Gastroenterology.
149:1825-1836.e5.
2015
|
|
| 2015
|
The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer.
Cancers.
7:1333-1348.
2015
|
|
| 2015
|
N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells.
Scientific Reports.
5.
2015
|
|
| 2014
|
MicroRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
Molecular Cancer.
13.
2014
|
|
| 2014
|
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.
Cancer Letters.
349:8-14.
2014
|
|
| 2014
|
Nonclassical HEDGEHOG-GLI signaling and its clinical implications.
International Journal of Cancer.
135:1-6.
2014
|
|
| 2014
|
Role of osteopontin in the pathophysiology of cancer.
Matrix Biology.
37:131-141.
2014
|
|
| 2014
|
Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.
Oncogene.
33:2620-2628.
2014
|
|
| 2014
|
Effect of niclosamide on basal-like breast cancers.
Molecular Cancer Therapeutics.
13:800-811.
2014
|
|
| 2014
|
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer.
Gynecologic Oncology.
134:112-120.
2014
|
|
| 2014
|
NMI and EMT.
Oncoscience.
1:476-477.
2014
|
|
| 2013
|
Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to smoothened-targeting Hedgehog inhibition.
Journal of Biological Chemistry.
288:11824-11833.
2013
|
|
| 2012
|
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.
Oncogene.
31:4979-4986.
2012
|
|
| 2012
|
DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.
Oncogene.
31:4472-4483.
2012
|
|
| 2012
|
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance.
FEBS Letters.
586:3429-3434.
2012
|
|
| 2012
|
Micro-RNA-632 downregulates DNAJB6 in breast cancer.
Laboratory Investigation.
92:1310-1317.
2012
|
|
| 2012
|
Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.
Oncogene.
31:3370-3380.
2012
|
|
| 2012
|
DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.
Biochemical Journal.
444:573-580.
2012
|
|
| 2012
|
Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ.
Experimental Cell Research.
318:1086-1093.
2012
|
|
| 2012
|
Dickkopf1: A tumor suppressor or metastasis promoter?.
International Journal of Cancer.
130:1477-1483.
2012
|
|
| 2012
|
Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases.
PLoS One.
7.
2012
|
|
| 2012
|
Location, location, location: The BRMS1 protein and melanoma progression.
BMC Medicine.
10.
2012
|
|
| 2012
|
Location, location, location: The BRMS1 protein and melanoma progression.
BMC Medicine.
10.
2012
|
|
| 2012
|
The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer..
International Journal of Breast Cancer.
2012:298623.
2012
|
|
| 2012
|
The influence of the cancer microenvironment on the process of metastasis..
International Journal of Breast Cancer.
2012:756257.
2012
|
|
| 2011
|
Loss of tumor suppressor merlin in advanced breast cancer is due to post-translational regulation.
Journal of Biological Chemistry.
286:40376-40385.
2011
|
|
| 2011
|
Hedgehog signaling: Networking to nurture a promalignant tumor microenvironment.
Molecular Cancer Research.
9:1165-1174.
2011
|
|
| 2011
|
Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.
Journal of Biological Chemistry.
286:9612-9622.
2011
|
|
| 2011
|
Recent advances in anti-angiogenic therapy of cancer.
Oncotarget.
2:122-134.
2011
|
|
| 2010
|
DNAJB6 induces degradation of β-catenin and causes partial reversal of mesenchymal phenotype.
Journal of Biological Chemistry.
285:24686-24694.
2010
|
|
| 2010
|
Functional characterization of the progestagen-associated endometrial protein gene in human melanoma.
Journal of Cellular and Molecular Medicine.
14:1432-1442.
2010
|
|
| 2010
|
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin.
Journal of Cellular and Molecular Medicine.
14:1693-1706.
2010
|
|
| 2010
|
Osteopontin: An effector and an effect of tumor metastasis.
Current Molecular Medicine.
10:71-81.
2010
|
|
| 2010
|
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1
2010
|
|
| 2009
|
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.
Clinical and Experimental Metastasis.
26:739-749.
2009
|
|
| 2009
|
The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin.
Journal of Biological Chemistry.
284:22888-22897.
2009
|
|
| 2009
|
Multi-faceted role of HSP40 in cancer.
Clinical and Experimental Metastasis.
26:559-567.
2009
|
|
| 2009
|
Nmi (N-Myc interactor) inhibits Wnt/β-catenin signaling and retards tumor growth.
International Journal of Cancer.
125:556-564.
2009
|
|
| 2009
|
Emerging role of nuclear protein 1 (NUPR1) in cancer biology.
Cancer and Metastasis Reviews.
28:225-232.
2009
|
|
| 2008
|
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
Clinical and Experimental Metastasis.
25:753-763.
2008
|
|
| 2008
|
Breast cancer metastasis-suppressor 1
2008
|
|
| 2008
|
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Current Cancer Drug Targets.
8:421-430.
2008
|
|
| 2008
|
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis..
BMC Medical Genomics.
1:13.
2008
|
|
| 2008
|
Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer
2008
|
|
| 2008
|
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Journal of Biological Chemistry.
283:7438-7444.
2008
|
|
| 2008
|
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Breast Cancer Research.
10.
2008
|
|
| 2008
|
BRMS1
2008
|
|
| 2008
|
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.
Cancer Genomics and Proteomics.
5:1-35.
2008
|
|
| 2007
|
Rac1 activity regulates proliferation of aggressive metastatic melanoma.
Experimental Cell Research.
313:3832-3839.
2007
|
|
| 2007
|
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation.
Molecular Cancer.
6.
2007
|
|
| 2006
|
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.
Biochemical and Biophysical Research Communications.
348:1429-1435.
2006
|
|
| 2006
|
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Cancer Letters.
235:260-265.
2006
|
|
| 2006
|
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Clinical and Experimental Metastasis.
23:123-133.
2006
|
|
| 2005
|
Radiotherapy basics for family physicians. Potent tool for symptom relief
2005
|
|
| 2005
|
Radiotherapy for the treatment of primary vaginal cancer.
Radiotherapy and Oncology.
77:133-136.
2005
|
|
| 2005
|
Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
Cancer Research.
65:713-717.
2005
|
|
| 2004
|
Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.
International Journal of Cancer.
111:693-697.
2004
|
|
| 2004
|
A small molecule antagonist of the αυβ 3 integrin suppresses MDA-MB-435 skeletal metastasis.
Clinical and Experimental Metastasis.
21:119-128.
2004
|
|
| 2004
|
Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
Clinical and Experimental Metastasis.
21:149-157.
2004
|
|
| 2004
|
Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription.
Journal of Biological Chemistry.
279:1562-1569.
2004
|
|
| 2004
|
Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12.
International Journal of Cancer.
108:15-22.
2004
|
|
| 2002
|
Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1.
Mammalian Genome.
13:289-292.
2002
|
|
| 2002
|
Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells.
Clinical and Experimental Metastasis.
19:95-105.
2002
|
|
| 2002
|
Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1)..
International Journal of Cancer.
97:15-20.
2002
|
|
| 2002
|
Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.
Experimental Cell Research.
273:229-239.
2002
|
|
| 2001
|
Analysis of mechanisms underlying BRMS1 suppression of metastasis.
Clinical and Experimental Metastasis.
18:683-693.
2001
|
|
| 2001
|
Metastasis suppression in prostate cancer.
Cancer and Metastasis Reviews.
20:279-286.
2001
|
|
| 2000
|
Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.
Cancer Research.
60:2764-2769.
2000
|
|
